Concepedia

Publication | Open Access

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

246

Citations

21

References

2010

Year

Abstract

The primary end point of the studies was met, indicating that telavancin is noninferior to vancomycin on the basis of clinical response in the treatment of HAP due to gram-positive pathogens.

References

YearCitations

Page 1